The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to the Securities and Exchange Commission (SEC)
by insider Culpepper Peter R since year 2005.
The trader's CIK number is 1281041.
At the time of this reporting, Culpepper Peter R is the Chief Financial Officer of Provectus Pharmaceuticals Inc .
(stock ticker symbol PVCT).
See this page for all insider trading activities at Provectus Pharmaceuticals Inc .
Stock purchases, sales, and option exercises reported by insider Culpepper Peter R since 2005.
Trade Date
Symbol
Company Name (Issuer)
Trade Type
Shares
Price ($)
Value ($)
2008-06-12
PVCT
Provectus Pharmaceuticals Inc
Option Exercise
44,795
1.10
49,274
2007-11-12
PVCT
Provectus Pharmaceuticals Inc
Option Exercise
50,000
.64
32,000
2007-09-13
PVCT
Provectus Pharmaceuticals Inc
Option Exercise
25,000
.64
16,000
2007-08-23
PVCT
Provectus Pharmaceuticals Inc
Option Exercise
75,000
.64
48,000
2006-11-30
PVCT
Provectus Pharmaceuticals Inc
Option Exercise
3,500
1.10
3,850
2006-10-30
PVCT
Provectus Pharmaceuticals Inc
Option Exercise
3,500
1.10
3,850
2006-09-28
PVCT
Provectus Pharmaceuticals Inc
Option Exercise
3,500
1.10
3,850
2006-08-30
PVCT
Provectus Pharmaceuticals Inc
Option Exercise
3,500
1.10
3,850
2006-07-30
PVCT
Provectus Pharmaceuticals Inc
Option Exercise
3,500
1.10
3,850
2006-07-05
PVCT
Provectus Pharmaceuticals Inc
Option Exercise
3,500
1.10
3,850
2006-04-30
PVCT
Provectus Pharmaceuticals Inc
Option Exercise
3,666
1.10
4,032
2006-05-30
PVCT
Provectus Pharmaceuticals Inc
Option Exercise
3,500
1.10
3,850
2006-03-31
PVCT
Provectus Pharmaceuticals Inc
Option Exercise
3,666
1.10
4,032
2006-02-28
PVCT
Provectus Pharmaceuticals Inc
Option Exercise
3,734
1.10
4,107
2006-01-31
PVCT
Provectus Pharmaceuticals Inc
Option Exercise
3,499
1.10
3,848
2005-12-31
PVCT
Provectus Pharmaceuticals Inc
Option Exercise
3,788
1.10
4,166
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Culpepper Peter R
(Chief Financial Officer of Provectus Pharmaceuticals Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
